Lee-Jah Chang

2.0k total citations
17 papers, 534 citations indexed

About

Lee-Jah Chang is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Lee-Jah Chang has authored 17 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 5 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Lee-Jah Chang's work include Influenza Virus Research Studies (7 papers), Respiratory viral infections research (7 papers) and Pneumonia and Respiratory Infections (3 papers). Lee-Jah Chang is often cited by papers focused on Influenza Virus Research Studies (7 papers), Respiratory viral infections research (7 papers) and Pneumonia and Respiratory Infections (3 papers). Lee-Jah Chang collaborates with scholars based in United States, France and Australia. Lee-Jah Chang's co-authors include John R. Mascola, Gary J. Nabel, Sandra Sitar, Robert T. Bailer, Julie E. Ledgerwood, Barney S. Graham, Mary E. Enama, Zonghui Hu, Richard A. Koup and W. Abdullah Brooks and has published in prestigious journals such as The Lancet, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Lee-Jah Chang

15 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lee-Jah Chang United States 10 277 224 167 95 58 17 534
Angelika Wagner Austria 12 165 0.6× 200 0.9× 47 0.3× 153 1.6× 22 0.4× 26 550
Sarah A. Frech United States 9 253 0.9× 195 0.9× 44 0.3× 371 3.9× 25 0.4× 10 815
Oliver Kürsteiner Switzerland 6 193 0.7× 158 0.7× 67 0.4× 131 1.4× 15 0.3× 10 416
Alison Han United States 14 500 1.8× 293 1.3× 102 0.6× 217 2.3× 17 0.3× 24 811
Krishanthi Subramaniam United Kingdom 18 243 0.9× 305 1.4× 333 2.0× 140 1.5× 13 0.2× 32 795
Christian Van Hoecke United States 11 292 1.1× 224 1.0× 134 0.8× 245 2.6× 12 0.2× 12 681
Obeid E. Obeid United Kingdom 16 271 1.0× 146 0.7× 31 0.2× 127 1.3× 41 0.7× 26 554
Elena Pettini Italy 17 132 0.5× 249 1.1× 57 0.3× 309 3.3× 58 1.0× 29 623
Carol Peterson United States 9 307 1.1× 161 0.7× 129 0.8× 27 0.3× 14 0.2× 10 471
Steve Rockman Australia 14 441 1.6× 240 1.1× 31 0.2× 293 3.1× 27 0.5× 26 777

Countries citing papers authored by Lee-Jah Chang

Since Specialization
Citations

This map shows the geographic impact of Lee-Jah Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee-Jah Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee-Jah Chang more than expected).

Fields of papers citing papers by Lee-Jah Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee-Jah Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee-Jah Chang. The network helps show where Lee-Jah Chang may publish in the future.

Co-authorship network of co-authors of Lee-Jah Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Lee-Jah Chang. A scholar is included among the top collaborators of Lee-Jah Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee-Jah Chang. Lee-Jah Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
4.
Chang, Lee-Jah, Evan J. Anderson, Robert Jeanfreau, et al.. (2021). Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trial. Vaccine. 39(11). 1572–1582. 1 indexed citations
5.
6.
Matsuoka, Osamu, Satoshi Inoue, Takahiro Inoue, et al.. (2019). Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial. Human Vaccines & Immunotherapeutics. 16(4). 858–866. 15 indexed citations
7.
8.
Dropulic, Lesia, Makinna Oestreich, Kerry J. Laing, et al.. (2019). A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection. The Journal of Infectious Diseases. 220(6). 990–1000. 51 indexed citations
9.
Chang, Lee-Jah, et al.. (2018). LB14. Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older. Open Forum Infectious Diseases. 5(suppl_1). S764–S764. 1 indexed citations
10.
11.
12.
Brooks, W. Abdullah, Lee-Jah Chang, Xiaohua Sheng, & Robert Hopfer. (2015). Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study. Vaccine. 33(36). 4610–4617. 52 indexed citations
13.
Chang, Lee-Jah, Kimberly A. Dowd, Floreliz Mendoza, et al.. (2014). Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. The Lancet. 384(9959). 2046–2052. 182 indexed citations
14.
Ledgerwood, Julie E., Kathryn L. Zephir, Zonghui Hu, et al.. (2013). Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect. The Journal of Infectious Diseases. 208(3). 418–422. 93 indexed citations
15.
Liu, Yu, Yongtao Sun, Lee-Jah Chang, et al.. (2012). Blockade of peanut allergy with a novel Ara h 2–Fcγ fusion protein in mice. Journal of Allergy and Clinical Immunology. 131(1). 213–221.e5. 36 indexed citations
16.
Chang, Lee-Jah, Susan Price, Katie Perkins, et al.. (2011). Mycophenolate Mofetil and Thrombopoietin Receptor Agonists in the Treatment of Refractory Thrombocytopenia in Patients with Autoimmune Lymphoproliferative Syndrome. Blood. 118(21). 2218–2218. 1 indexed citations
17.
Chang, Lee-Jah, Annette S. Uss, Inhou Chu, et al.. (2009). The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification. Journal of Pharmaceutical and Biomedical Analysis. 51(5). 1069–1077. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelika Wagner Breakdown of academic impact, for papers by Sarah A. Frech Breakdown of academic impact, for papers by Oliver Kürsteiner Breakdown of academic impact, for papers by Alison Han Breakdown of academic impact, for papers by Krishanthi Subramaniam Breakdown of academic impact, for papers by Christian Van Hoecke Breakdown of academic impact, for papers by Obeid E. Obeid Breakdown of academic impact, for papers by Elena Pettini Breakdown of academic impact, for papers by Carol Peterson Breakdown of academic impact, for papers by Steve Rockman
Rankless by CCL
2026